normal volunteer

normal volunteer

NIHspeak A person used to study normal physiology and behavior or who does not have a condition being studied in a particular protocol, used to compare with subjects who do have the condition
Mentioned in ?
References in periodicals archive ?
The charities didn't know the exact reason why I was there - they thought I was just a normal volunteer," said Asif, aged 33, from Yardley.
BioCell Technology LLC has released results from a double-blind clinical study showing that the naturally occurring hyaluronic acid (HA) in the BioCell Collagen II[R] product has significant peak absorption and steady state bioavailability in normal volunteer subjects.
These trials are typically more challenging to recruit and retain than traditional Phase I Healthy Normal Volunteer (HNV) trials.
Coley's Phase Ia normal volunteer study was designed to evaluate Actilon's safety, dose tolerability and immunological activity.
He said: "Each sibling has only a one in four chance of most cases have to depend on normal volunteers on the international registers.
Preclinical beta-amyloid deposition in the brains of cognitively normal volunteers was associated with poor sleep quality but not sleep quantity, according to researchers.
Normal volunteers were treated over 3 days with LMS at four different dose levels and were monitored for toxicity and immunologic changes.
In a control group of normal volunteers, high IQ was associated with a lower degree of worry, but in those diagnosed with GAD, high IQ was associated with a greater degree of worry.
This pilot investigation aimed to specifically measure lymphatic flow using non invasive nuclear medicine 'gold standard' pre and post herbal medicine interventions of a standardised herbal formulation of horsechestnut (Aesculus hippocastanum), butcher's broom (Ruscus aculeatus) and ginkgo (Ginkgo biloba) (Horsechestnut Complex[R]) in a group of normal volunteers.
Nasdaq:LXRX), The Woodlands, Texas, a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, has successfully completed a Phase 1 multiple-dose escalation study in normal volunteers with LX1031, its oral drug candidate for irritable bowel syndrome (IBS).
Our goal is to determine the macrophage response to wear debris in cells from normal volunteers and patients with and without periprosthetic osteolysis and the association of the magnitude of the response or the incidence of the disease with particular TLR45, CD14, and TLR2 polymorphisms.
Samples with normal value: normal volunteers in the lab